Print Friendly, PDF & Email

CT imaging Technology Debuts in Canada

The value of computed tomography (CT) scanning is unquestionable. A clear CT scan provides physicians with the detailed information they need to diagnose conditions, plan surgical intervention or monitor treatment.  There has always been a trade-off with regard to CT image quality. A higher radiation dose in a CT examination results in a clearer image, but a higher dose also increases the patient’s long-term health risk.

The tug-of-war between dose and image quality is changing, however. New advanced reconstruction technologies are able to produce far better images from CT scans that are acquired using a lower dose, and GE Healthcare is leading the way in bringing these tools to hospitals around the world. ^

Now available in Canada, Veo* is the world’s first model-based iterative reconstruction product for CT, offering less noise and higher resolution within a single image, and offers additional capability for cases where the highest image quality at even lower dose is required.+

When compared to previous reconstruction methods, Veo’s capabilities “change the rules” of CT imaging by applying revolutionary new modeling techniques to potentially deliver lower noise, increased resolution, improved low contrast detectability and fewer artifacts.  Responding to radiologists’ demand for maximum CT image clarity and optimized low dose for their patients, Veo represents a powerful new tool that can help physicians more clearly visualize anatomy in order to deliver informed, accurate and confident diagnoses.

“The recent release of Veo in Canada offers radiologists the opportunity to expand on the gains made by Adaptive Statistical Iterative Reconstruction (ASiR),” said Dr. Jonathon Leipsic, Head of Radiology, Providence Health, St. Paul’s Hospital in Vancouver. “Veo has the potential to push radiation dose lower across organ systems while reducing image noise and improving spatial resolution – which would allow for more robust imaging of small structures and more confident assessment of heavily calcified arteries, an ongoing challenge in CT angiography.”

Developed in partnership with leading academic researchers and experts from GE’s Global Research Center, Veo is available with the Discovery* CT750 HD, a ‘healthymagination-certified’ product, meaning that it helps enable better healthcare for more people by helping improve cost, quality, and/or access to healthcare technology.

* Trademark of General Electric Company

^ Veo is 510(k) Pending and not available in the US

+ In clinical practice, the use of Veo may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.